Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 163

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 163
---
) since October 2010 where he teaches among others, Homeopathy Practitioner Advance Diploma Course. Mr. To holds professional homeopath qualification and is awarded the Honorary Fellowship of the Faculty of Homeopathy (UK). Mr. To has led the Hong Kong Association of Homeopathy and the Macau Association of Homeopathy as president since 2005 and has been the vice president of the Committee of Comprehensive Health Industries in the China Hong Kong Economic Trading International Association since 2023 We believe that Mr. To is qualified to serve as our director because of his experience in the Homeopathy industry and his extensive knowledge of the Company.

Mr. Yuan Liang Zhanghas been serving
as our Chief Financial Officer since August 2024. Mr. Zhang has been serving as a Financial Director at Guangzhou Cool Trip Travel Agency
Co., Ltd. from December 2021 to June 2022. Prior to that, he served as a Senior Finance Director at Zhejiang Panshi Information Technology
C, Ltd. from December 2019 to December 2020. From December 2018 to July 2019, Mr. Zhang served as Finance Director of Wanda Sports Group
Company Limited. From October 2010 to September 2018, Mr. Zhang served as an Assurance Manager at Ernst & Young Hua Ming LLP. Mr.
Zhang holds a Bachelor’s degree in International Accounting from Nankai University.

Mr. Shing Hei Leehas been serving
as our Director since August 2024. Mr. Lee has been serving a Representative of Head & Shoulders Securities Limited from February
2023 till present, and was an Equity Capital Markets Associate of the same from April 2018 to January 2023. Mr. Lee was primarily focused
on deal origination, transaction negotiation and execution, syndication work and research. Mr. Lee holds a Master of Arts degree from
University of Edinburgh. We believe that Mr. Lee is qualified to serve as our director because of his extensive experience in capital
markets.

Mr. Chun Fai Fong is an independent
director nominee and will serve as an independent director of the Company upon the effectiveness of the registration statement of which
this prospectus forms a part. Mr. Fong has been serving as the President of Mango Financial Limited since October 2024. From September
2023 to September 2024, he served as advisor (CFO) of 91360 Med Tech (Nanjing) Co., Ltd. From August